| 000 | 01741 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250516200402.0 | ||
| 264 | 0 | _c20140604 | |
| 008 | 201406s 0 0 eng d | ||
| 022 | _a1432-1335 | ||
| 024 | 7 |
_a10.1007/s00432-014-1618-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhao, Jingya | |
| 245 | 0 | 0 |
_aThe use of mutation-specific antibodies in predicting the effect of EGFR-TKIs in patients with non-small-cell lung cancer. _h[electronic resource] |
| 260 |
_bJournal of cancer research and clinical oncology _cMay 2014 |
||
| 300 |
_a849-57 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies _xgenetics |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aErbB Receptors _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 700 | 1 | _aWang, Xiaoying | |
| 700 | 1 | _aXue, Liang | |
| 700 | 1 | _aXu, Nuo | |
| 700 | 1 | _aYe, Xin | |
| 700 | 1 | _aZeng, Haiying | |
| 700 | 1 | _aLu, Shaohua | |
| 700 | 1 | _aHuang, Jie | |
| 700 | 1 | _aAkesu, Sujie | |
| 700 | 1 | _aXu, Chen | |
| 700 | 1 | _aHe, Deming | |
| 700 | 1 | _aTan, Yunshan | |
| 700 | 1 | _aHong, Qunying | |
| 700 | 1 | _aWang, Qun | |
| 700 | 1 | _aZhu, Guanshan | |
| 700 | 1 | _aHou, Yingyong | |
| 700 | 1 | _aZhang, Xin | |
| 773 | 0 |
_tJournal of cancer research and clinical oncology _gvol. 140 _gno. 5 _gp. 849-57 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00432-014-1618-2 _zAvailable from publisher's website |
| 999 |
_c23579436 _d23579436 |
||